UPM-Kymmene (UPM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Comparable EBIT increased by 60% year-over-year in Q2 2024 to EUR 182 million, driven by improved demand, Paso de los Toros pulp mill ramp-up, and despite high maintenance activity and political strikes in Finland.
Sales in Q2 2024 were EUR 2,546 million, nearly flat compared to Q2 2023.
Strategic actions included new business-specific labor agreements in Finland, planned closures of Hürth newsprint mill and Nordland Papier machine, and the acquisition of Grafityp to expand in graphics.
UPM Biochemicals is preparing for production start at Leuna by year-end, with robust customer interest and partnerships.
High maintenance activity and political strikes in Finland impacted H1 2024 results, but assets are now positioned for strong H2 performance.
Financial highlights
Q2 2024 comparable EBIT was EUR 182 million (7.2% of sales), up from EUR 114 million (4.5%) in Q2 2023.
Net debt at end of Q2 2024 was EUR 2,763 million; net debt/EBITDA at 1.64.
Dividend payment of EUR 400 million in Q2 2024; EUR 1.50/share for 2023 paid in two instalments.
Maintenance and strike impacts totaled EUR 180 million in H1 2024.
H1 2024 operating cash flow was EUR 539 million, down from EUR 1,173 million in H1 2023.
Outlook and guidance
Full-year 2024 comparable EBIT expected to increase from 2023, supported by higher volumes, Paso de los Toros ramp-up, and lower fixed costs.
H2 2024 comparable EBIT expected to exceed H1, especially in UPM Fibres, with no major maintenance shutdowns scheduled.
Market conditions for renewable fuels expected to remain weak; margin management and cost reduction actions ongoing.
Energy-related refunds expected in Q4, similar to previous years.
Latest events from UPM-Kymmene
- Q4 2025 delivered strong cash flow and strategic actions despite lower sales and EBIT.UPM
Q4 20254 Feb 2026 - Balanced global growth, strong cash flow, and sustainability drive future returns.UPM
CMD 202422 Jan 2026 - Q3 EBIT up 32% to EUR 291m, with cost actions and strategic moves supporting outlook.UPM
Q3 202418 Jan 2026 - Comparable EBIT up 21% to EUR 1,224m in 2024; H1 2025 EBIT seen at EUR 400–625m.UPM
Q4 20249 Jan 2026 - Comparable EBIT fell 14% as sales stayed flat and strategic actions continued amid uncertainty.UPM
Q1 202520 Dec 2025 - Joint venture valued at EUR 1.42bn to deliver EUR 100m annual synergies by end-2026.UPM
Partnership7 Dec 2025 - Q2 2025 earnings fell on lower prices and trade headwinds, but advanced materials and biofuels outperformed.UPM
Q2 20254 Nov 2025 - Sales and EBIT fell sharply, but advanced materials and energy showed resilience.UPM
Q3 202529 Oct 2025 - Balanced, sustainable portfolio with resilient advanced materials and biofuels amid trade headwinds.UPM
Investor Presentation29 Oct 2025